<?xml version="1.0" encoding="UTF-8"?>
<p>Scientists from all over the world are coming together and working simultaneously to fight against this deadly disease. However, so far, specific therapies regarding the treatment have been too little, and measures that have been implied are restricted to limited supportive and preventive therapies. Experimental trials have been carried out using a combination of lopinavir/ritonavir, which are commonly used to treat human immunodeficiency virus (HIV) infection [
 <xref rid="B10-molecules-25-03936" ref-type="bibr">10</xref>]. Another experiment using four FDA approved drugs, including nelfinavir, pitavastatin, perampanel, and praziquantel, identified nelfinavir as a potent inhibitor for SARS-CoV-2 M
 <sup>pro</sup> enzyme [
 <xref rid="B11-molecules-25-03936" ref-type="bibr">11</xref>]. Although trials have already been carried out for the treatment of SARS-CoV-2 infection, preliminary investigations remain unapproved regarding their use.
</p>
